Anil Potti and his colleagues have retracted another paper, “Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma,” originally published in the December 15, 2009, issue of Clinical Cancer Research.
According to the notice: Continue reading Tenth Potti retraction appears, in Clinical Cancer Research
The International Journal of Impact Engineering has a highly technical retraction of an article whose authors discovered that crucial findings relied on a model that was different from the one they reported using in a particular figure.
The article, “Dynamic behavior of polymers at high strain-rates based on split Hopkinson pressure bar tests,” was published online last November by a pair of researchers from the U.K. and China. As the notice states:
Continue reading Flawed model leads to retraction of polymer paper
A retraction notice from Tissue Antigens:
The following article from Tissue Antigens, A gene-specific primer extension and liquid bead array system for killer cell immunoglobulin-like receptor genotyping by H. J. Park, Y. Oh, H. J. Kang, E. J. Han, H. Y. Shin, H. S. Ahn, K. S. Ahn, B. H. Yoon & B. D. Han, published online on 14 March 2011 in Wiley Online Library (http://onlinelibrary.wiley.com) and in Tissue Antigens, 77:535–539, has been retracted by agreement between the authors, the journal Editor-in-Chief, James McCluskey, and Blackwell Publishing Ltd. The retraction has been agreed due to inadvertent publication of the same article in a prior issue of the journal: Park, H. J., Oh, Y., Kang, H. J., Han, E. J., Shin, H. Y., Ahn, H. S., Ahn, K. S., Yoon, B. H. and Han, B. D. (2011), A gene-specific primer extension and liquid bead array system for killer-cell immunoglobulin-like receptor genotyping.Tissue Antigens, 77:251–256. Blackwell Publishing Ltd. accepts responsibility for this error. Continue reading Oops! Tissue Antigens retracts paper after accidentally publishing it twice
Three journals belonging to the American Heart Association are dealing with a data manipulation case involving a Japanese scientist who collaborated with some of the United States’ most prominent cardiac specialists.
Circulation has retracted a 2008 article after the researchers said the lead author’s sloppy record-keeping prevented them from reproducing their experiments. We think there might be a bit more to the story.
Here’s the notice: Continue reading Three AHA journals retract lipid papers over “negligent” record-keeping, image issues and more
A 60 Minutes segment Sunday on Anil Potti has drawn national attention to the case, so we thought this would be a good time to compile all of the retractions and corrections in one place.
Duke has said that about a third of Potti’s 40-some-odd papers would be retracted, and another third would have “a portion retracted with other components remaining intact,” so this list will continue to grow. We’ll update it as we hear about new changes.
Retractions: Continue reading The Anil Potti retraction record so far
We knew we hadn’t heard the last of Joachim Boldt, whose nearly 90 retractions make him the putative record holder for a single author in this indistinguished club. But we didn’t expect this:
The European Journal of Anaesthesiology has retracted a paper, “Supplemental oxygen reduces serotonin levels in plasma and platelets during colorectal surgery and reduces postoperative nausea and vomiting,” from Boldt’s former colleagues at the Klinikum Ludwigshafen after determining that the authors were trying to hide their association with the disgraced anesthesiologist.
Continue reading Not so fast! Journal retracts paper from Boldt group over author hijinks, more
Anil Potti can add two corrections to his less-and-less impressive publication record. The mega-corrections — part of what we are close to being ready to call a trend in errata notices — in the Journal of Clinical Oncology (JCO) are, however, quite impressive, each with at least a dozen points.
One of the corrections, for a paper cited 15 times, according to Thomson Scientific’s Web of Knowledge, basically removes all references to chemotherapy sensitivity: Continue reading Two mega-corrections for Anil Potti in the Journal of Clinical Oncology
Whether it’s a one-off or a sign of things to come, Bharat Aggarwal
, the MD Anderson scientist at the center of a blogospheric storm—and an institutional investigation—over the validity of his data, has had a paper withdrawn by the journal Cancer Letters. Continue reading MD Anderson researcher Aggarwal loses paper in Cancer Letters
A dozen years might seem like a publishing eternity, but the European Journal of Cancer
has decided to purge a duplicate paper from 2000. The article, on the utility of the prostate-specific antigen (PSA) test for detecting prostate cancer, comes from a group whose work in this area has been widely cited as evidence for the benefits of the highly controversial screening tool.
“Prostate cancer screening in the Tyrol, Austria: experience and results,” by a group of Austrian researchers, has a rather complicated past. It’s been cited 42 times, according to Thomson Scientific’s Web of Knowledge. Here’s the notice, which appeared in a recent issue of the journal: Continue reading Duplication forces retraction of paper by group whose work is used to justify prostate-specific antigen (PSA) testing
Authors’ financial disclosures can be a thorny issue for scientific journals. There’s often confusion over just what should be listed as a conflict of interest, and when relationships are revealed after papers are published, lack of disclosure sometimes leads to corrections.
For example, the Journal of Cell Science recently published this: Continue reading Coming clean: A major figure in cardiology publishes a lengthy conflict of interest correction in JAMA